- call +1-201-465-4211
- email sales@mrinsights.biz
Rheumatic heart disease is a complication ofrheumatic fever in which the heart valves are damaged.
Scope of the Report:
Increasing environmental pollution resulting in higher prevalence of viral and fungal infection is one of the major factor motivating the growth of this market. In addition, increasing healthcare expenditure by government to tackle rising prevalence of cardiovascular disease is another motivating factor for the market.
The global Rheumatic Heart Disease market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rheumatic Heart Disease.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Rheumatic Heart Disease market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rheumatic Heart Disease market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott Laboratories
Bayer
BIOTRONIK
Boston Scientific
Bristol-Myers Squibb
C. R. Bard
Cardinal Health
Cook Medical
Roche
GE Healthcare
InterValve
Novartis
On-X Life Technologies
Osypka Medical
Otsuka
PerkinElmer
Pfizer
Reckitt Benckiser
Siemens Healthineers
Toray
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Valve
Myocarditis
Pericarditis
Market Segment by Applications, can be divided into
Hospital
Diagnostic Centre
Research Centre
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Rheumatic Heart Disease Market Overview
1.1 Product Overview and Scope of Rheumatic Heart Disease
1.2 Classification of Rheumatic Heart Disease by Types
1.2.1 Global Rheumatic Heart Disease Revenue Comparison by Types (2017-2023)
1.2.2 Global Rheumatic Heart Disease Revenue Market Share by Types in 2017
1.2.3 Valve
1.2.4 Myocarditis
1.2.5 Pericarditis
1.3 Global Rheumatic Heart Disease Market by Application
1.3.1 Global Rheumatic Heart Disease Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital
1.3.3 Diagnostic Centre
1.3.4 Research Centre
1.4 Global Rheumatic Heart Disease Market by Regions
1.4.1 Global Rheumatic Heart Disease Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Rheumatic Heart Disease Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Rheumatic Heart Disease Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rheumatic Heart Disease Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Rheumatic Heart Disease Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rheumatic Heart Disease Status and Prospect (2013-2023)
1.5 Global Market Size of Rheumatic Heart Disease (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Rheumatic Heart Disease Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Rheumatic Heart Disease Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.3 BIOTRONIK
2.3.1 Business Overview
2.3.2 Rheumatic Heart Disease Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BIOTRONIK Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.4 Boston Scientific
2.4.1 Business Overview
2.4.2 Rheumatic Heart Disease Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Boston Scientific Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bristol-Myers Squibb
2.5.1 Business Overview
2.5.2 Rheumatic Heart Disease Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.6 C. R. Bard
2.6.1 Business Overview
2.6.2 Rheumatic Heart Disease Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 C. R. Bard Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cardinal Health
2.7.1 Business Overview
2.7.2 Rheumatic Heart Disease Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cardinal Health Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cook Medical
2.8.1 Business Overview
2.8.2 Rheumatic Heart Disease Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cook Medical Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.9 Roche
2.9.1 Business Overview
2.9.2 Rheumatic Heart Disease Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Roche Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.10 GE Healthcare
2.10.1 Business Overview
2.10.2 Rheumatic Heart Disease Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GE Healthcare Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.11 InterValve
2.11.1 Business Overview
2.11.2 Rheumatic Heart Disease Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 InterValve Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.12 Novartis
2.12.1 Business Overview
2.12.2 Rheumatic Heart Disease Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Novartis Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.13 On-X Life Technologies
2.13.1 Business Overview
2.13.2 Rheumatic Heart Disease Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 On-X Life Technologies Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.14 Osypka Medical
2.14.1 Business Overview
2.14.2 Rheumatic Heart Disease Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Osypka Medical Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.15 Otsuka
2.15.1 Business Overview
2.15.2 Rheumatic Heart Disease Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Otsuka Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.16 PerkinElmer
2.16.1 Business Overview
2.16.2 Rheumatic Heart Disease Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 PerkinElmer Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.17 Pfizer
2.17.1 Business Overview
2.17.2 Rheumatic Heart Disease Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Pfizer Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.18 Reckitt Benckiser
2.18.1 Business Overview
2.18.2 Rheumatic Heart Disease Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Reckitt Benckiser Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.19 Siemens Healthineers
2.19.1 Business Overview
2.19.2 Rheumatic Heart Disease Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Siemens Healthineers Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.20 Toray
2.20.1 Business Overview
2.20.2 Rheumatic Heart Disease Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Toray Rheumatic Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
3 Global Rheumatic Heart Disease Market Competition, by Players
3.1 Global Rheumatic Heart Disease Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Rheumatic Heart Disease Players Market Share
3.2.2 Top 10 Rheumatic Heart Disease Players Market Share
3.3 Market Competition Trend
4 Global Rheumatic Heart Disease Market Size by Regions
4.1 Global Rheumatic Heart Disease Revenue and Market Share by Regions
4.2 North America Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
4.3 Europe Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
4.5 South America Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
5 North America Rheumatic Heart Disease Revenue by Countries
5.1 North America Rheumatic Heart Disease Revenue by Countries (2013-2018)
5.2 USA Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
5.3 Canada Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
5.4 Mexico Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
6 Europe Rheumatic Heart Disease Revenue by Countries
6.1 Europe Rheumatic Heart Disease Revenue by Countries (2013-2018)
6.2 Germany Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
6.3 UK Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
6.4 France Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
6.5 Russia Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
6.6 Italy Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Rheumatic Heart Disease Revenue by Countries
7.1 Asia-Pacific Rheumatic Heart Disease Revenue by Countries (2013-2018)
7.2 China Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
7.3 Japan Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
7.4 Korea Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
7.5 India Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
8 South America Rheumatic Heart Disease Revenue by Countries
8.1 South America Rheumatic Heart Disease Revenue by Countries (2013-2018)
8.2 Brazil Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
8.3 Argentina Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
8.4 Colombia Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Rheumatic Heart Disease by Countries
9.1 Middle East and Africa Rheumatic Heart Disease Revenue by Countries (2013-2018)
9.2 Saudi Arabia Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
9.3 UAE Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
9.4 Egypt Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
9.5 Nigeria Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
9.6 South Africa Rheumatic Heart Disease Revenue and Growth Rate (2013-2018)
10 Global Rheumatic Heart Disease Market Segment by Type
10.1 Global Rheumatic Heart Disease Revenue and Market Share by Type (2013-2018)
10.2 Global Rheumatic Heart Disease Market Forecast by Type (2018-2023)
10.3 Valve Revenue Growth Rate (2013-2023)
10.4 Myocarditis Revenue Growth Rate (2013-2023)
10.5 Pericarditis Revenue Growth Rate (2013-2023)
11 Global Rheumatic Heart Disease Market Segment by Application
11.1 Global Rheumatic Heart Disease Revenue Market Share by Application (2013-2018)
11.2 Rheumatic Heart Disease Market Forecast by Application (2018-2023)
11.3 Hospital Revenue Growth (2013-2018)
11.4 Diagnostic Centre Revenue Growth (2013-2018)
11.5 Research Centre Revenue Growth (2013-2018)
12 Global Rheumatic Heart Disease Market Size Forecast (2018-2023)
12.1 Global Rheumatic Heart Disease Market Size Forecast (2018-2023)
12.2 Global Rheumatic Heart Disease Market Forecast by Regions (2018-2023)
12.3 North America Rheumatic Heart Disease Revenue Market Forecast (2018-2023)
12.4 Europe Rheumatic Heart Disease Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Rheumatic Heart Disease Revenue Market Forecast (2018-2023)
12.6 South America Rheumatic Heart Disease Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Rheumatic Heart Disease Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Rheumatic Heart Disease Picture
Table Product Specifications of Rheumatic Heart Disease
Table Global Rheumatic Heart Disease and Revenue (Million USD) Market Split b
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
